ArticleCanadian liver journal2018
In the eyes of Indigenous people in Canada: exposing the underlying colonial etiology of hepatitis C and the imperative for trauma-informed care.
Article in Canadian liver journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 31 citations in OpenAlex.
- Visual storytelling as democratizing knowledge: relational concepts of transdisciplinary health impact through film.Global health promotion · 2026Article
- Article
- A milestone for theCanadian liver journal · 2025Article
- Epidemiology of Chronic Hepatitis C in First Nations Populations in Canadian Prairie Provinces.Pathogens (Basel, Switzerland) · 2025Review
- Hepatitis C Diagnosis and Treatment Among Indigenous People in a Canadian Context: Challenges and Community-Led Solutions.Microorganisms · 2024Review
- Hepatitis C (HCV) prevalence in citizens of the Métis Nation of Ontario.BMC infectious diseases · 2024Article
- How Etuaptmumk/Two-Eyed Seeing is used in Indigenous health research: A scoping review.PloS one · 2024Article
- Infectious diseases in Indigenous populations in North America: learning from the past to create a more equitable future.The Lancet. Infectious diseases · 2023Review
- Public health interventions, priority populations, and the impact of COVID-19 disruptions on hepatitis C elimination among people who have injected drugs in Montreal (Canada): A modeling study.The International journal on drug policy · 2023Article
- Lessons from First Nations partnerships in hepatitis C research and the co-creation of knowledge.Canadian liver journal · 2023Article
- Diabetic foot complications among Indigenous peoples in Canada: a scoping review through theFrontiers in endocrinology · 2023Article
- A collaborative approach to hepatitis C testing in two First Nations communities of northwest Ontario.Canadian liver journal · 2022Article
- ECHO+: Improving access to hepatitis C care within Indigenous communities in Alberta, Canada.Canadian liver journal · 2022Article
- Achieving HCV micro-elimination in rural communities.Canadian liver journal · 2021Article
- Treating hepatitis C during the COVID-19 pandemic in Alberta.Canadian liver journal · 2021Article
- How is Etuaptmumk/Two-Eyed Seeing characterized in Indigenous health research? A scoping review.PloS one · 2021Article
- Perspectives of Saskatchewan researchers and community members on HIV-1 strains circulating in Saskatchewan.AIDS (London, England) · 2020Article
- A scoping review of school-based indigenous substance use prevention in preteens (7-13 years).Substance abuse treatment, prevention, and policy · 2020Article
- "Every One of Us Is a Strand in That Basket": Weaving Together Stories of Indigenous Wellness and Resilience From the Perspective of Those With Lived and Living Experience With HIV/Hepatitis C Virus.The Journal of the Association of Nurses in AIDS Care : JANACArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 6 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The distribution of hepatitis C (HCV) infection in Canada signals a widening gap between Indigenous and non-Indigenous people. Current evidence demonstrates that the rate of HCV infection among Indigenous people is at least five times higher than the rest of Canada. This analysis provides a reconciliatory response, which exposes the colonial etiology of the HCV gap in Canada and proposes potential anti-colonial approaches to HCV wellness and health care for Indigenous people. Methods: This analysis applies Two-Eyed Seeing as a reconciliatory methodology to advance the understanding of HCV burden and identify the key elements of responsive HCV care in the context of Indigenous nations in Canada. Results: The analysis underlines the colonial distribution of HCV burden in Canada, highlights Indigenous perspectives on HCV infection, hypothesizes a clinical pathway for the underlying colonial etiology of HCV infection, and identifies Indigenous healing as a promising anti-colonial conceptual approach to HCV wellness and health care among Indigenous people. Conclusions: In the eyes of Indigenous people, HCV infection is a colonial illness that entails healing as an anti-colonial approach to achieving wellness and gaining health. Future empirical research should elaborate on the colonial HCV pathway hypothesis and inform the development of a framework for HCV healing among Indigenous people in Canada.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.